Alginates & Derivatives Market by Class (Type I Fast Setting, Type II Normal Setting), Type (Ammonium Alginate, Calcium Alginate, Magnesium Alginate), Form, Application - Global Forecast 2024-2030

Alginates & Derivatives Market by Class (Type I Fast Setting, Type II Normal Setting), Type (Ammonium Alginate, Calcium Alginate, Magnesium Alginate), Form, Application - Global Forecast 2024-2030


The Alginates & Derivatives Market size was estimated at USD 718.58 million in 2023 and expected to reach USD 762.49 million in 2024, at a CAGR 6.50% to reach USD 1,116.75 million by 2030.

Alginate & derivatives are the compounds found within the cell walls of brown algae. The alginate is combined with water to create a viscous gum paste, perfect for molding dental impressions or other small-scale products. Alginates are derived from seaweed and have a variety of uses, including the manufacture of food additives, pharmaceutical products, cosmetics, detergents, and textiles. Increasing demand for natural ingredients and their ability to provide a renewable alternative to synthetic materials is accelerating the use of alginates and their derivatives in the textile industry. Derivatives such as algae-based polysaccharides are used in food products as thickening agents and stabilizers. However, functional issues and complexities to large-scale production may adversely impact the use of alginates & derivatives. Moreover, the growing focus on developing renewable and novel alginates & derivatives and expanding applications in biomedicine are expected to facilitate the usage of alginates & derivatives across end-use industries worldwide.

Regional Insights

The alginates & derivatives are steadily growing in the Americas owing to the increasing demand for processed food products with improved textures and shelf-life and the rising production of personal care and pharmaceutical products. Growing consumer inclination towards healthy lifestyles is also boosting the demand for natural ingredients such as alginates & derivatives in the food and beverage industry in the APAC region. The rising focus on drug development and the introduction of growing usage of food-grade alginates, owing to their use as a stabilizer and emulsifier in food products, is expanding the use of alginates & derivatives in the EMEA region. Additionally, advances in pharmaceutical technology, growing demand for alginate-based drug delivery systems, and growing focus on developing safe, natural, and organic products are expected to encourage the adoption of alginates & derivatives by the end-use industries across the globe.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Alginates & Derivatives Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
  • Growing demand for sodium alginate for ceramic and textile industries
  • Rapid adoption of processed food & beverages
  • Applications of alginates & derivatives in biomedicine and tissue engineering
Market Restraints
  • Functional issues associated with the use of alginates & derivatives
Market Opportunities
  • Increasing R&D activities to develop renewable raw material sources to expand their applications
  • Proliferation of antimicrobial and antiviral therapy with the alginate-based drugs
Market Challenges
  • Difficulty to process on large scale due to complex nature
Market Segmentation Analysis
  • Class: Higher preferences for type I alginates & derivatives to create rapid gelling forms
  • Application: Growing adoption of alginates & derivatives as thickening agent in the food and personal care industry
Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Alginates & Derivatives Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Alginates & Derivatives Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

JRS Group acquires seaweed processor

The JRS Group, a global supplier of alginates and derivatives, recently acquired a seaweed processor as part of their ongoing efforts to expand their product portfolio. As the demand for alginates continues to rise, this acquisition helps the company meet its growth objectives while ensuring it can provide high-quality products at competitive prices. This move indicates how the market is evolving and how those in the algae sector are adapting to meet changing customer demands. It also serves as a reminder that the need for algae products such as alginates has continued to rise over the years and is expected to continue in that trend in the near future. With new suppliers entering the market and existing ones looking to increase their capacity, this acquisition is an exciting development for all stakeholders involved.

Klaria Pharma Holding AB receives 2,6 MSEK (USD 249.31 thousand) payment from Imbrium Therapeutics in the Epinephrine Alginate Film R&D Collaboration

Klaria Pharma Holding AB recently announced a 2.6 MSEK payment from Imbrium Therapeutics to research and develop an epinephrine alginate film which is a significant development for the alginates & derivatives market. This investment helps create new opportunities to develop treatments that use this specialized film to deliver pharmaceuticals currently unavailable in existing formats. The payment also highlights how Imbrium Therapeutics values Klaria's research capabilities and expertise in developing such products, which would increase demand for alginates & derivatives in this industry. Furthermore, the potential success of this research could open up several opportunities to further develop treatments using alginates & derivatives in the near future.

PLASTISEA concludes after successful development of biodegradable packaging with alginate extracted from algae

PLASTISEA, a joint project of AITIIP and the Spanish Ministry of Economic Affairs and Digital Transformation, has successfully produced biodegradable packaging with alginates extracted from algae. Alginates are derived from brown algae found in seawater or brackish water environments. This technology has potential applications in both commercial and industrial sectors, including food packaging, consumer products, and medical devices. Using alginates as a biodegradable alternative is beneficial to reduce environmental impacts associated with traditional plastics, such as non-biodegradability, toxicity, and accumulation of plastic debris. Additionally, this technology has the potential to create new market opportunities for the alginates and derivatives industry worldwide. Market research indicates strong growth for sustainable materials such as alginate-based products due to rising consumer demand for eco-friendly products. As a result, players in the alginates & derivatives industry need to leverage this opportunity by offering innovative solutions based on this technology.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Alginates & Derivatives Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Alginates & Derivatives Market, highlighting leading vendors and their innovative profiles. These include AEP Colloids, Barentz International BV, Brenntag SE, Cargill, Incorporated, CD Bioparticles, CELLINK Bioprinting AB by BICO Group AB, COMPAÑIA ESPAÑOLA DE ALGAS MARINAS S A, DuPont de Nemours, Inc., FMC Corporation, Gino Gums & Stabilizers, Iro Alginate Industry Co., Ltd., J. Rettenmaier & Söhne GmbH + Co KG, KIMICA Corporation, LABH ADDITIVES, Lianyungang Fengyun Seaweed Manufacturer Co.,Ltd., Marine Biopolymers Ltd., Marine Hydrocolloids, McKinley Resources Inc., Meron Group, Newstetic USA, Penta Manufacturing Company, Powder Pack Chem, Prinova Group LLC, Qingdao bright moon seaweed group co., LTD., Qingdao Hyzlin Biology Development Co.,Ltd., S.R.K. Enterprises, Shandong Jiejing Group Co., Ltd., SNP, Inc., Spectrum Laboratory Products, Inc., The Ingredient House, and Wego Chemical Group.

Market Segmentation & Coverage

This research report categorizes the Alginates & Derivatives Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Class
  • Type I Fast Setting
  • Type II Normal Setting
  • Type
  • Ammonium Alginate
  • Calcium Alginate
  • Magnesium Alginate
  • Potassium Alginate
  • Propylene Glycol Alginate
  • Sodium Alginate
  • Zinc Alginate
  • Form
  • Filamentous
  • Gel
  • Powder
  • Application
  • Fertilizers
  • Food & Beverage
  • Industrial
  • Personal Care
  • Pharmaceutical
  • Region
  • Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom


Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for sodium alginate for ceramic and textile industries
5.1.1.2. Rapid adoption of processed food & beverages
5.1.1.3. Applications of alginates & derivatives in biomedicine and tissue engineering
5.1.2. Restraints
5.1.2.1. Functional issues associated with the use of alginates & derivatives
5.1.3. Opportunities
5.1.3.1. Increasing R&D activities to develop renewable raw material sources to expand their applications
5.1.3.2. Proliferation of antimicrobial and antiviral therapy with the alginate-based drugs
5.1.4. Challenges
5.1.4.1. Difficulty to process on large scale due to complex nature
5.2. Market Segmentation Analysis
5.2.1. Class: Higher preferences for type I alginates & derivatives to create rapid gelling forms
5.2.2. Application: Growing adoption of alginates & derivatives as thickening agent in the food and personal care industry
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Alginates & Derivatives Market, by Class
6.1. Introduction
6.2. Type I Fast Setting
6.3. Type II Normal Setting
7. Alginates & Derivatives Market, by Type
7.1. Introduction
7.2. Ammonium Alginate
7.3. Calcium Alginate
7.4. Magnesium Alginate
7.5. Potassium Alginate
7.6. Propylene Glycol Alginate
7.7. Sodium Alginate
7.8. Zinc Alginate
8. Alginates & Derivatives Market, by Form
8.1. Introduction
8.2. Filamentous
8.3. Gel
8.4. Powder
9. Alginates & Derivatives Market, by Application
9.1. Introduction
9.2. Fertilizers
9.3. Food & Beverage
9.4. Industrial
9.5. Personal Care
9.6. Pharmaceutical
10. Americas Alginates & Derivatives Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Alginates & Derivatives Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Alginates & Derivatives Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. JRS Group acquires seaweed processor
13.3.2. Klaria Pharma Holding AB receives 2,6 MSEK (USD 249.31 thousand) payment from Imbrium Therapeutics in the Epinephrine Alginate Film R&D Collaboration
13.3.3. PLASTISEA concludes after successful development of biodegradable packaging with alginate extracted from algae
13.3.4. Textiles From Seaweed Moves A Step Closer As AlgiKnit Raises USD 13 Million In Series A Funding
13.3.5. Klaria and PharmaMar initiate collaboration with a one-year study to develop a clinical development candidate of a PharmaMar compound formulated in Klaria’s Alginate Film technology
13.3.6. Klaria Pharmaceuticals enters into Agreement with FluiMed GmbH to develop Sirolimus Alginate Film for prevention of Organ Transplant Rejection
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings